Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
about
Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathologyHistone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinomaNCAM and FGFR1 coexpression and colocalization in renal tumorsEpigenetic inactivation of HOXA11, a novel functional tumor suppressor for renal cell carcinoma, is associated with RCC TNM classification.Network of microRNA, transcription factors, target genes and host genes in human mesothelioma.TGF-β mediated DNA methylation in prostate cancer.Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genesClinical potential of TCF21 methylation in the diagnosis of renal cell carcinomaHypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma.Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carcinomaGenome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma.Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma.Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma.Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.Improving needle biopsy accuracy in small renal mass using tumor-specific DNA methylation markersNon-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities.Hypomethylating agents for urologic cancers.Pathology, therapy and prognosis of papillary renal carcinoma.The epigenetic landscape of renal cancer.Epigenetic silencing of Na,K-ATPase β 1 subunit gene ATP1B1 by methylation in clear cell renal cell carcinoma.DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma.Identification of DNA Methylation-Independent Epigenetic Events Underlying Clear Cell Renal Cell Carcinoma.MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data.The epigenetic landscape of clear-cell renal cell carcinoma.Targeting DNA Methyltranferases in Urological Tumors.
P2860
Q26752925-C6E8361A-4A60-4B44-A46A-40F95138817BQ27025984-3DBB2B71-D2A0-4B58-A5A9-90BDF27F5897Q33582911-996403D4-9693-4673-B58A-79B229EDAFBCQ33591712-F8C3ABE1-866F-4440-B5A9-246D48B371A8Q33744408-8456C1D1-F70A-4909-A28B-9A346F86AF25Q34039935-04CA3B85-8037-4B6B-845C-141BA137A8C9Q34438914-4062B78A-7893-48C8-8C69-8A726E17FD8DQ34534982-46D4838B-91CD-4DC2-A1CA-CB40D55234FEQ35016547-47C007FA-9924-4F51-A1FA-8FD2449C9105Q35606411-6155B1A3-7328-4D19-B486-3350DF3DEF89Q35911266-27824785-6B2E-480D-99B0-D9C7061478D4Q36014320-88357531-C491-463F-88A7-1FA9B0CECFC2Q36163659-2F53FA28-84AF-4D04-8490-F75CFF84CBCEQ36584397-B285DCD5-BEB1-480C-A552-502D9F7E0325Q36891899-20D51BAD-8DBD-4727-8A0B-89992CFF9C5EQ37359513-A6A9CA21-9487-4844-B8CA-5E2D05A1F3F1Q37484160-D36DC53B-6479-46CD-A309-36B997663006Q37706374-AE2F6298-9787-481B-8FE0-D4FEAD3B3421Q37836508-BD256359-A658-4858-9AF3-155B7598DFE8Q37854737-4211D361-1D0F-4AD5-9151-986E79EAE394Q38312048-A9EA2454-E64C-4DA1-B2A4-7FCFBA8DA90DQ39021700-9E817822-2938-48B6-9B3E-0326DC8BE907Q39031771-08C047E5-9C8B-4C5D-8879-02CBDEAC77C5Q40937833-52E1EC4A-67F5-4638-896D-285866006485Q41574276-A6D6AD8A-EE48-4AB0-96D1-FE0879F6BAA0Q42011951-AC378EA4-E800-4B51-BDDD-A59C0901AA9AQ42775763-8B8818EC-AC96-4B86-B1AD-A57BF4B5A284Q47271339-A7C7894C-ACA8-4F1E-8E27-2ED3A5277673Q51091490-2CD7A4E0-65E9-46A4-BF64-ADC1DE5900B2Q55435258-84D5938A-9AB6-4FB8-BBF2-66BD27FDB0B3
P2860
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
@en
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics.
@nl
type
label
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
@en
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics.
@nl
prefLabel
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
@en
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics.
@nl
P2860
P356
P1433
P1476
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
@en
P2093
Eamonn R Maher
Mark R Morris
P2860
P2888
P356
10.1186/GM180
P577
2010-09-03T00:00:00Z
P5875
P6179
1029431810